Apoptosis, Caspase Activation Inhibitor (AVEN) (Middle Region) Peptide
AVEN
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all AVEN products
- AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- GAPRGSRREP GGWGAGASAP VEDDSDAETY GEENDEQGNY SKRKIVSNWD
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- AVEN Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
- Synonyms
- AVEN Peptide, pdcd12 Peptide, aven Peptide, wu:fc08c09 Peptide, si:ch211-150c22.4 Peptide, PDCD12 Peptide, 1700013A01Rik Peptide, 1700056A21Rik Peptide, mAven-L Peptide, mAven-S Peptide, apoptosis and caspase activation inhibitor Peptide, apoptosis, caspase activation inhibitor L homeolog Peptide, apoptosis, caspase activation inhibitor Peptide, Aven Peptide, AVEN Peptide, aven.L Peptide, aven Peptide
- Background
-
Protects against apoptosis mediated by Apaf-1.
Alias Symbols: PDCD12
Protein Size: 362 - Gene ID
- 57099
- NCBI Accession
- NM_020371, NP_065104
- UniProt
- Q9NQS1
-
You are here:
